Associate Director, SOX
GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly
Find Pharma, Biotech, Clinical Research & Medical Jobs on Bioksha
GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly
GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly
GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly
GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly
GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly
GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly
GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance mom
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance mom
About the Role: GSK’s Enterprise AI team, a highly skilled applied AI group, translates the promise of AI into measurable impact across every major group at GSK — R&D, Medical, Commercial, Supply Chai
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance mom
GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance mom
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance mom
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance mom
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance mom
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance mom
GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly
Business Introduction GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance mom
GSK remains committed to achieving bold commercial ambitions for the future By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly
Looking for something specific?
Browse all job categories →